MYBPHL

myosin binding protein H like, the group of I-set domain containing|Myosin binding proteins

Basic information

Region (hg38): 1:109292365-109307011

Links

ENSG00000221986NCBI:343263OMIM:619807HGNC:30434Uniprot:A2RUH7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • familial dilated cardiomyopathy (Limited), mode of inheritance: Unknown

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MYBPHL gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MYBPHL gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
32
clinvar
1
clinvar
33
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
17
clinvar
17
Total 0 0 33 0 20

Variants in MYBPHL

This is a list of pathogenic ClinVar variants found in the MYBPHL region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-109294170-G-C Benign (May 13, 2021)1268365
1-109294213-A-G Benign (May 13, 2021)1245843
1-109294220-C-G Benign (May 13, 2021)1222087
1-109294929-A-G Benign (May 13, 2021)1287601
1-109295086-G-A Benign (May 21, 2021)1276114
1-109295125-C-T not specified Uncertain significance (Jul 09, 2021)2235701
1-109295161-G-A not specified Uncertain significance (Aug 30, 2021)2216577
1-109295188-A-G not specified Uncertain significance (Aug 02, 2021)2392218
1-109295219-A-G not specified Uncertain significance (Feb 28, 2023)2490485
1-109295494-C-T Benign (May 13, 2021)1264859
1-109296211-T-C Benign (May 13, 2021)1282714
1-109296296-C-T Benign (May 04, 2021)1253160
1-109296323-C-T not specified Uncertain significance (Feb 11, 2022)2309942
1-109296338-G-A Brugada syndrome Uncertain significance (Mar 06, 2023)994289
1-109296441-AT-A Benign (May 13, 2021)1268940
1-109296441-A-AT Benign (May 13, 2021)1238412
1-109296770-A-G Benign (May 13, 2021)1180903
1-109296778-C-T Benign (May 04, 2021)1289852
1-109296791-T-C not specified Uncertain significance (Jan 03, 2024)3154431
1-109296801-C-T not specified Uncertain significance (Jan 31, 2023)3154427
1-109296804-G-A not specified Uncertain significance (May 29, 2024)3297247
1-109296809-G-A not specified Uncertain significance (Dec 06, 2021)2265135
1-109296811-A-G Benign (May 04, 2021)1265643
1-109296837-C-T not specified Uncertain significance (Feb 21, 2024)3154423
1-109296849-C-T not specified Uncertain significance (Oct 12, 2021)2254768

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MYBPHLprotein_codingprotein_codingENST00000357155 814677
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.003690.98812536503831257480.00152
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4042052220.9240.00001352271
Missense in Polyphen5470.0930.7704789
Synonymous-0.4179590.01.060.00000559743
Loss of Function2.32717.50.4018.29e-7193

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005720.000572
Ashkenazi Jewish0.001690.00169
East Asian0.0001630.000163
Finnish0.003140.00315
European (Non-Finnish)0.002120.00212
Middle Eastern0.0001630.000163
South Asian0.001010.00101
Other0.001630.00163

dbNSFP

Source: dbNSFP

Recessive Scores

pRec
0.105

Intolerance Scores

loftool
0.670
rvis_EVS
0.6
rvis_percentile_EVS
82.83

Haploinsufficiency Scores

pHI
hipred
N
hipred_score
0.285
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.172

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mybphl
Phenotype
muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); endocrine/exocrine gland phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype;

Gene ontology

Biological process
biological_process
Cellular component
cellular_component
Molecular function
molecular_function;protein binding